Evolus (EOLS) EBT Margin Growth (1y) (2020 - 2026)
Evolus (EOLS) EBT Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn | 1,487.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,487.00 |
| Mar 31, 2026 | 1,322.00 |
| Dec 31, 2025 | 861.00 |
| Sep 30, 2025 | 859.00 |
| Jun 30, 2025 | -773.00 |
| Mar 31, 2025 | -545.00 |
| Dec 31, 2024 | 1,118.00 |
| Sep 30, 2024 | 262.00 |
| Jun 30, 2024 | 1,982.00 |
| Mar 31, 2024 | 1,338.00 |
| Dec 31, 2023 | 1,081.00 |
| Sep 30, 2023 | 2,599.00 |
| Jun 30, 2023 | 2,637.00 |
| Mar 31, 2023 | 1,622.00 |
| Dec 31, 2022 | 2,239.00 |
| Sep 30, 2022 | 1,302.00 |
| Jun 30, 2022 | -334.00 |
| Mar 31, 2022 | -10,401.00 |
| Dec 31, 2021 | 48,626.00 |
| Sep 30, 2021 | -776.00 |